/PRNewswire/ -- Cyrex Laboratories, a clinical laboratory specializing in functional immunology and autoimmunity, today announced the launch of BiomeBurden

/PRNewswire/ -- Cyrex Laboratories，一家专注于功能免疫学和自身免疫的临床实验室，今天宣布推出BiomeBurden

its newest innovation in gut biome testing. This advanced 3-panel testing approach is designed to uncover multiple immune responses to microbes, yeast, and mold, including antibodies, lymphocytes, and T cells.

其在肠道生物群测试中的最新创新。这种先进的三面板测试方法旨在揭示对微生物、酵母和霉菌的多种免疫反应，包括抗体、淋巴细胞和T细胞。

The foundational MycoBiomeBurden panel screens for 6 key

基础的 MycoBiomeBurden 面板筛查 6 种关键

Candida

念珠菌病

species, multiple

物种，多个

Candida

念珠菌

Albican virulence factors such as germ tube and candidalysin, and several food-derived molds. The second panel MicroBiomeBurden expands detection to several cross-reactive tissue antigens, 3 species of aerobic bacteria, and 4 species of anaerobic bacteria. The third panel, BiomeBurden

白色念珠菌的毒力因子，如芽管和念珠菌素，以及几种食物来源的霉菌。第二个面板MicroBiomeBurden扩展了检测范围，包括几种交叉反应的组织抗原、3种需氧菌和4种厌氧菌。第三个面板，BiomeBurden

Complete,

完成，

includes the first two panels plus several flow cytometry tests for T-cell function and lymphocyte activity of Th1, Th2, and Th17 —all critical indicators of potential immune response to the tested antigens.

包含前两个面板以及针对Th1、Th2和Th17的T细胞功能和淋巴细胞活性的几项流式细胞术测试——这些都是对测试抗原潜在免疫反应的关键指标。

In recent years, both patients and healthcare providers have become increasingly aware of the important role that the gut microbiome plays in supporting immune health and balance. When this delicate balance is disrupted—especially by an overgrowth of certain fungal species—it can trigger chronic inflammation and impact overall well-being.

近年来，患者和医疗保健提供者都越来越意识到肠道微生物组在支持免疫健康和平衡方面的重要作用。当这种微妙的平衡被打破时——尤其是由于某些真菌种类的过度生长——它可能引发慢性炎症并影响整体健康。

Candida species, while naturally present in the body, can become problematic in certain individuals when they grow out of balance. This overgrowth has been linked to ulcerative colitis, liver autoimmunity, Rett syndrome, and other autoimmune conditions. By identifying these imbalances early, there is an opportunity to better understand the root causes of chronic symptoms and take proactive steps toward improved long-term health..

念珠菌属的物种虽然在体内自然存在，但在某些个体中，当它们生长失衡时可能会引发问题。这种过度生长与溃疡性结肠炎、肝脏自身免疫、雷特综合征及其他自身免疫疾病有关。通过早期识别这些失衡，就有机会更好地理解慢性症状的根本原因，并采取积极措施改善长期健康。

'This launch marks a key milestone for our company as we continue to transform how people understand and manage their health,' said

“这次发布标志着我们公司的一个关键里程碑，因为我们继续改变人们对健康的认识和管理方式，”

Mark McDonough

马克·麦克多诺

, CEO of Cyrex Laboratories. 'With BiomeBurden™, Cyrex is redefining microbial testing by focusing on immune activation—not just presence of antigens—to reveal how the body is actively responding. We have designed these panels to empower healthcare practitioners to uncover hidden microbial triggers through an expanded screening of potential immune responses that may drive chronic conditions.

Cyrex实验室首席执行官表示：“通过BiomeBurden™，Cyrex正在重新定义微生物检测，重点关注免疫激活，而不仅仅是抗原的存在，以此揭示身体如何积极反应。我们设计了这些检测面板，旨在帮助医疗从业者通过扩大对可能导致慢性疾病的潜在免疫反应的筛查，发现隐藏的微生物诱因。”

It's a more personalized, preventive approach—one focused on identifying root causes, not just managing symptoms.'.

它是一种更个性化、预防性的方法——专注于识别根本原因，而不仅仅是管理症状。

BiomeBurden is the result of over 20 years of research and development by Aristo Vojdani PhD, considered the father of Functional Medicine and a pioneer in this field with over 20 patents and numerous industry-changing innovations.

BiomeBurden 是 Aristo Vojdani 博士超过 20 年研发的成果，他被认为是功能医学之父，并且是该领域的先驱，拥有 20 多项专利和众多改变行业的创新。

'Unlike traditional stool or swab tests that focus primarily on the gut, the BiomeBurden™ blood test offers a more comprehensive view of the body's immune response to fungal and microbial triggers,' said Dr. Vojdani, Chief Scientific Advisor of Cyrex. 'By analyzing immune markers in the blood, we can assess not only the presence of specific organisms but also how the immune system is reacting across multiple systems—not just the gut.

“与主要关注肠道的传统粪便或拭子测试不同，BiomeBurden™ 血液测试提供了身体对真菌和微生物触发因素的免疫反应的更全面视角，”Cyrex 首席科学顾问 Vojdani 博士说道。“通过分析血液中的免疫标志物，我们不仅可以评估特定生物的存在，还可以了解免疫系统在多个系统中的反应，而不仅仅是肠道。”

This provides clinicians with a better understanding of how the mycobiome and microbiome contribute to autoimmunity, as well as a deeper, more holistic understanding of a patient's overall immune health.' .

这使临床医生更好地理解了真菌组和微生物组如何影响自身免疫，以及更深入、更全面地了解患者的整体免疫健康。

All Cyrex Arrays are available to consumers exclusively through an order from a physician or other licensed healthcare professional. To learn more about the BiomeBurden test series or any of the many other Cyrex Arrays that are part of the Cyrex System, please visit

所有 Cyrex 检测项目仅可通过医生或其他持有执照的医疗专业人员的订单向消费者提供。要了解更多关于 BiomeBurden 测试系列或 Cyrex 系统中的许多其他 Cyrex 检测项目，请访问

About Cyrex Laboratories:

关于Cyrex实验室：

Cyrex Laboratories is a clinical immunology laboratory specializing in a proactive, personalized patient- focused approach to functional immunology and autoimmunity. Our laboratory offers multi-tissue antibody testing for early detection and monitoring of today's complex autoimmune conditions. It develops innovative testing arrays through continuous collaboration with leading experts in medical research and clinical practice.

Cyrex Laboratories是一家临床免疫学实验室，专注于功能免疫学和自身免疫的前瞻性、个性化患者导向方法。本实验室提供多组织抗体测试，用于早期检测和监控当今复杂的自身免疫状况。通过与医学研究和临床实践领域的领先专家持续合作，实验室开发了创新的测试组合。

The Cyrex system is built on several pillars of excellence to include the antigen purification system, the optimized antigen concentration, and the antigen-specific validation process. Cyrex is based in .

Cyrex系统建立在多个卓越支柱之上，包括抗原纯化系统、优化的抗原浓度，以及抗原特异性验证过程。Cyrex位于。